Ibuprofen 200Mg Oral Cap for Tooth Decay

"That is correct, the clinical trial indicated on clinicaltrials.gov is still looking for patients. The study was posted on 8/9/2022 and updated as recently as 8/22/2022. They are hoping to enroll 294 people at 1 location."

"The sponsor of this study, Reckitt Benckiser Healthcare (UK) Limited, is measuring the main objective over a 0-8 hour period. This will be done by assessing the Summed Pain Intensity Difference 0-8 hours (SPID0-8) vs placebo using the Numeric Rating Scale (NRS) for pain. Additionally, the study will also look at secondary outcomes including Time to onset of pain relief using double stopwatch method vs Placebo and Proportion of subjects using rescue medication vs Active Comparator. The former is defined as Time to onset of meaningful pain relief (measured as time to perceptible"

"Ibuprofen 200Mg Oral Cap is considered safe."

"Eligible patients for this research should have dental diseases and be between 16 to 55 years old. In total, the study will allow up to 294 individuals to participate."

"In order to qualify for this trial, patients must be aged 16-55. If you are not in this age bracket, there are 17 other trials specifically designed for people under 18 and 19 additional trials available for those over 65."

"That is correct. The clinicaltrials.gov website currently has this trial listed as open and recruiting patients. This trial was originally posted on 8/9/2022 and updated on 8/22/2022. They are looking to enroll 294 individuals at 1 site."